As of August 28, 2026, Aspire Biopharma Holdings, Inc. (ASBP) has a DilutionWatch DilutionScore of 76/100, rated CRITICAL dilution risk. Aspire Biopharma Holdings, Inc. has a market capitalization of $7.11M, 1.40M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $20.00M, 44.00M outstanding warrants.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 52%
📜 Warrant Exercise
model 60%
• Massive warrant overhang: 3137% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion
model 60%
• Major convertible overhang: 144% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise
model 20%
• Active shelf registration ($20M, 281% of market cap)
Market Data
Market Cap$7.11M
Shares Outstanding1.40M
Float1.20M
Cash$12.17M
Debt$1.50M
Short InterestN/A
Institutional Holdings
10 institutional holders · 12.5K shares
#1
UBS Group AG
6.4K shares
#2
Morgan Stanley
2.6K shares
#3
Geode Capital Management, LLC
1.4K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest79.9K
Days to Cover1.5
% of Float6.7%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2025-12-31
xbrl
XBRL WARRANT
2024-12-31
8-K
8K EVENT
2026-06-22
8-K/A
8K EVENT
2026-04-17
8-K
8K EVENT
2026-04-16
Full SEC filing analysis available with free account
→
Factual ASBP Dilution Snapshot
Aspire Biopharma Holdings, Inc. (ASBP) has a DilutionScore of 76/100, rated Critical dilution risk. Score date: August 28, 2026.
- Stored shelf registration capacity: $20.0M.
- Stored outstanding warrants: 44.0M.
- Recent SEC activity tracked for ASBP: 8-K on 2026-06-22; 8-K/A on 2026-04-17; 8-K on 2026-04-16.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track ASBP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ASBP — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for ASBP
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.